FDA Approves Vertex’s JOURNAVX as First Non-Opioid Acute Pain Treatment
FDA Approves JOURNAVXTM (Suzetrigine): A breakthrough in Non-Opioid pain Management In a landmark decision, the U.S.Food and Drug Administration (FDA) has approved JOURNAVXTM (suzetrigine), the first oral medication of its kind, for the treatment of moderate to severe acute pain in adults. Developed by Vertex Pharmaceuticals, this innovative drug marks a notable shift in … Read more
